Global diabetic shoes Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Global diabetic shoes Market Research Report 2024-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2030

Diabetic shoes are shoes designed for diabetic patients. With the improvement of people's living standards, more and more diabetic patients are facing various serious complications. Among them, one of the most common problems is diabetic foot. Diabetic foot refers to patients who are newly diagnosed with diabetes or have a history of diabetes and have infection, ulceration or tissue destruction in the foot, accompanied by lower limb neuropathy and/or peripheral arterial disease. These foot ulcers, or open sores, primarily occur on the bottom of the foot because many people with diabetes have neuropathy, or nerve damage, and lose the ability to feel pain in the feet.

Diabetic protective shoes can reduce the risk of diabetic foot ulcers and reduce patients' chances of amputation. Professional diabetic protective shoes can provide diabetic patients with foot support and protection, minimizing the impact on high-pressure areas of the feet, which ordinary shoes cannot meet. Whether at home or abroad, there are many research data and clinical practices showing that professional diabetic protective shoes have a significant effect in preventing diabetic foot and improving the early symptoms of diabetic foot.

Market Overview:

The latest research study on the global diabetic shoes market finds that the global diabetic shoes market reached a value of USD 784.76 million in 2023. It’s expected that the market will achieve USD 1240.52 million by 2029, exhibiting a CAGR of 7.93% during the forecast period.

Improper wearing of shoes and socks by diabetic patients leads to more than 21% to 33% of diabetic foot ulcers, and ulcers are an independent risk factor for amputation. 85% of amputations in diabetic patients are caused by foot ulcers. The International Clinical Guidelines for Diabetic Foot clearly states that appropriate shoes and socks can reduce abnormal plantar pressure, reduce the occurrence of calluses and ulcers, and prevent foot damage. With the development of science and technology, researchers have designed and produced special diabetic shoes and insoles according to the needs of diabetic patients to prevent the occurrence of diabetic foot ulcers. Appropriate shoes and socks can reduce abnormal plantar pressure, reduce the occurrence of calluses and ulcers, and prevent foot injuries. The selection and wearing of appropriate footwear and socks play an important role in the prevention of diabetic foot.

Effectiveness of Diabetic Shoes

Clinically, it is believed that diabetic footwear has a significant effect in preventing the initial onset and recurrence of diabetic foot ulcers. Overseas, diabetic shoes have been used as a treatment method to prevent diabetic foot ulcers for decades, and a large number of experiments have been done to test the effectiveness of diabetic shoes. Maciejew Ski et al. conducted a 9-month study on 241 diabetic patients with a high risk of foot ulcers. The study found that compared with patients wearing ordinary shoes, patients wearing diabetic shoes had lower pressure at the metatarsophalangeal joint, The landing time and contact ratio were significantly reduced. At the same time, the probability of foot ulcers and amputation rate of patients wearing diabetic shoes was also significantly lower than that of the control group.

Chinese scholars have gradually realized the important role of diabetic shoes in the prevention and care of diabetic foot ulcers, and have done a lot of relevant experimental research to confirm the effectiveness of diabetic shoes. Yang Chuan et al. randomly selected 54 patients from 252 patients with type 2 diabetes to conduct a shoe-wearing experiment, and asked the subjects to conduct dynamic plantar pressure tests in three states: barefoot, wearing ordinary shoes, and wearing diabetic shoes. The test results show that the special in-shoe design of diabetic shoes can reduce local high pressure to a certain extent, thereby balancing the pressure on the sole of the foot. Through a large number of experiments by domestic and foreign scholars, the effectiveness of diabetic shoes has been fully proven.

Regarding the prevention of foot ulcers in diabetic patients, Australia's Guidelines for Wearing Shoes for Diabetic Patients published in 2013 and 2018 clearly stated that wearing specially customized diabetic shoes or used with foot orthotics is the best way to prevent foot ulcers in diabetic patients. The essential. The effectiveness of diabetic shoes is driving the growth in demand.

Region Overview:

From a regional perspective, North America, Europe, and Asia-Pacific are the three largest revenue markets. In 2022, North America, Europe, and Asia-Pacific will reach 39.39%, 29.63%, and 23.93% respectively.

Company Overview:

Dr. Comfort

Founded in 2002 and headquartered in Mequon, Wisconsin, Dr. Comfort has recognized the needs of the diabetes footwear industry for quality, comfort and style. Dr. Comfort brings together the latest technology and footwear designers to create the best diabetic shoes for people with diabetes or other foot conditions that affect their daily lives. Since its introduction, Dr. Comfort has continued to design diabetic shoes that look as good as they feel.

FinnComfort

FinnComfort company has always stood at the international level, providing first-class, practical and comfortable shoes for different needs. At FinnComfort's modern factory in Hasfurt am Main, FinnComfort not only produces a wide range of footwear solutions, but also develops them in-house. Experienced orthopedic surgeons, podiatrists and orthopedic shoemakers have been involved in the design of FinnComfort lasts and have supported the expansion of the product range.

Segmentation Overview:

The main subdivision types of diabetes shoe products are men and women. Among them, men's diabetes shoes will occupy a larger market size in 2022, accounting for 53.36%. In the future, the global diabetes shoes market has broad prospects and investment potential.

Application Overview:

The diabetes shoe industry can be divided into online sales and offline sales according to application. From the perspective of application fields, offline sales are the largest application market, with the market sales share reaching 84.20% in 2018 and 80.56% in 2022. In 2022, the online sales market share will be 19.44%. In general, as the demand for diabetic shoes in downstream applications increases, the demand for diabetic shoes in the market continues to grow, and the diabetic shoe industry is booming.

Key Companies in the global diabetic shoes market covered in Chapter 3:

FinnComfort
Propet
I-Runner
Jianxing Shoes (Foshan City) Co., LTD
Pilgrim Shoes
Apex Foot
Drew Shoe
Dr. Comfort
DARCO International
Orthofeet
Anodyne

In Chapter 4 and Chapter 14.2, on the basis of types, the diabetic shoes market from 2019 to 2030 is primarily split into:

men
Miss

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the diabetic shoes market from 2019 to 2030 covers:

online sales
Offline sales

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2019-2030) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)